Advertisement

Responsive Advertisement
urope led the global EPO drug market in 2021 closely followed by North America
Asian countries for drug discovery and development since market for health care process is more in Asia Pacific region
North America to maintain the lion's share by 2026
Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 56.7% during the forecast period
Asia-Pacific would exhibit the highest CAGR during the forecast period.
Snapshot of Asia-Pacific intelligent asthma monitoring devices market
Saudi Arabia is expected grow at the highest CAGR of 9.8%, owing to the presence of ample growth opportunities in terms of unmet medical needs and increasing healthcare investments
Global powered surgical instrument market is expected to exhibit significant growth during the forecast period
The hospital segment is projected to grow at the highest CAGR of 5.9% during the forecast period
Azoles projected to be the primary drug type in the near future
The private cord blood bank segment is expected to register the highest growth rate during the forecast period